AFT Pharmaceuticals posts $11 mln first-half loss after boosting R&D spend, launching OTC products

AFT Pharmaceuticals posts $11 mln first-half loss after boosting R&D spend, launching OTC products
Fiona Rotherham
By Fiona Rotherham Nov. 24 (BusinessDesk) - AFT Pharmaceuticals, the Auckland-based drug-maker, widened its first-half loss to $11 million from $5.8 million after ramping up research and development and launching over-the-counter products in Australia and Singapore. The figures confirm a market trading update the company supplied earlier this month. Cash on hand dropped to $16 million from $28 million the previous year and the company said it had the financial flexibility to increase cash reserves with further drawn downs available on its...